Skip to main content
Jianmin Pharmaceutical Group Co., Ltd. logo

Jianmin Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 600976 ISIN · CNE000001HB7 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,559 across all filing types
Latest filing 2026-04-17 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600976

About Jianmin Pharmaceutical Group Co., Ltd.

https://www.whjm.com/

Jianmin Pharmaceutical Group Co., Ltd. is a specialized pharmaceutical enterprise with a heritage dating back to 1637. The company focuses on the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern healthcare products. Its core portfolio emphasizes pediatric health, gynecological treatments, and chronic disease management. Key products include Longmu Zhuanggu Granules, recognized for supporting bone development and overall health in children. The group integrates traditional pharmacological wisdom with contemporary biotechnology and standardized production processes. Jianmin Group operates through a comprehensive value chain encompassing raw material sourcing, advanced manufacturing, and a distribution network. By leveraging its status as a time-honored brand, the company maintains a strong market position in the pediatric TCM segment while expanding its presence in general wellness and prescription drug markets.

Recent filings

Filing Released Lang Actions
健民集团2026年度“提质增效重回报”行动方案
Regulatory Filings Classification · 85% confidence The document is a strategic “action plan” for 2026 (“提质增效重回报行动方案”) detailing operations, R&D, governance enhancements and investor communication. It is not an Annual Report (10-K), Earnings Release (ER), Management Discussion and Analysis (MDA) or Investor Presentation (IP) but rather a mandated plan filing under exchange guidelines. It does not present financial statements nor announce a separate report. It fits best as a miscellaneous regulatory announcement (Regulatory Filings).
2026-04-17 Chinese
健民集团2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a shareholder meeting resolution announcement for the year 2025, detailing the resolutions passed at the Annual General Meeting (AGM) held on April 10, 2026. It includes voting results on various proposals such as the 2025 annual report, profit distribution, board reports, and other corporate matters. The document is a formal announcement of the voting results from the AGM, not the full report or detailed financial statements themselves. It also includes legal opinions confirming the validity of the meeting and voting process. The document length is 4535 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-04-10 Chinese
健民集团2025年年度股东会会议资料
AGM Information Classification · 100% confidence The document is a detailed set of materials for the 2025 Annual General Meeting (AGM) of 健民药业集团股份有限公司, including the agenda, meeting procedures, and various proposals to be voted on by shareholders. It includes references to the 2025 Annual Report, profit distribution plan, board reports, and other governance matters, all scheduled for discussion and approval at the AGM on April 10, 2026. The document is comprehensive and clearly intended as meeting materials for the AGM rather than a simple announcement or a transcript. Therefore, it fits the category of AGM Information (AGM-R).
2026-04-01 Chinese
健民药业集团股份有限公司章程修订对照表
Governance Information Classification · 95% confidence The document is a detailed comparison table showing amendments to the company's Articles of Association (公司章程), including governance-related provisions such as board duties, management responsibilities, and committee names. It references compliance with corporate governance guidelines (《上市公司治理准则》). The content focuses on governance structure and rules rather than financial data, earnings, or meeting results. The document is not a report of financial results, audit, or legal proceedings, nor is it an announcement of a report. It is a governance-related document detailing internal rules and board structure changes. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 3243 characters, which is consistent with a detailed governance amendment document rather than a brief announcement or a full annual report.
2026-03-20 Chinese
健民集团董事会审计委员会对中审众环2025年度审计工作的监督与评价
Audit Report / Information Classification · 95% confidence The document is a detailed report from the Board Audit Committee regarding the supervision and evaluation of the accounting firm Zhongshen Zhonghuan CPA Firm's audit work for the fiscal year 2025. It discusses the audit firm's qualifications, the audit process, communications, and the committee's evaluation of the audit work. The document references the 2025 annual audit and the preparation of the 2025 annual report but does not contain the full annual report or financial statements itself. It is a standalone audit-related report focusing on the audit firm's performance and oversight, which fits the definition of an Audit Report / Information (AR). The document length is 2066 characters, which is relatively short but contains substantive content about the audit work and evaluation, not merely an announcement or certification. Therefore, it is classified as AR with high confidence.
2026-03-20 Chinese
健民集团关于运用自有闲置资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the use of its own idle funds for cash management by investing in low-risk financial products. It details the investment amount, types of products, risk warnings, approval procedures, and impact on the company. It is a formal disclosure about a financing activity involving the company's capital management, not a full financial report or earnings release. The document length is about 3,097 characters, which is relatively short and focused on a specific capital/financing update. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2026-03-20 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.